You'll also receive updates on new products, special offers, and expert-backed articles to help you make informed decisions about your health
You're not alone, and you're right on schedule for what researchers call "Quitter's Day" - the second Friday in January, when most New Year's resolutions go to die
Susan Spratt, an endocrinologist and senior medical director for the Population Health Management Office at Duke Health in North Carolina, said that although Zepbound provided more weight loss than Wegovy, both drugs are highly effective
8.2 Cost-effectiveness and health economic implications The elevated cost of acquisition of GLP-1 receptor agonists convey major challenges for healthcare systems, with yearly treatment expenses between $10,000 and $15,000 USD, markedly surpassing those of conventional diabetic drugs (Kong et al